Author

P. Hayashi

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Trends in the etiologies and outcomes of idiosyncratic drug-induced liver injury in the united states: The DILIN prospective registry, 2004 to 2024.

BACKGROUND AIMS Idiosyncratic drug-induced liver injury (DILI) is an infrequent cause of liver disease. The aim of this study is to report on temporal changes in the etiology and outcomes of idiosyncratic DILI in the United States DILIN Prospective study. METHODS The presenting clinical features and outcomes of conse...

R. Fontana, N. Chalasani, P. Hayashi et al. · Hepatology · 0 citations

Review Sep 2026

Drug-Induced Liver Injury (DILI) in clinical trials: Views and practical updates from DILI specialists at FDA.

Eight key topics that may benefit from review, clarification, research, and discussion between industry, academia, and regulators as the FDA works to address DILI risk assessment are highlighted.

P. Hayashi, Mark I. Avigan · Hepatology · 0 citations